The Time Is Right for These Seven Biotechs

The Time Is Right for These Seven Biotechs
“In most years, biotechs decline in the spring as investors anticipate a summer hiatus in the conferences where new clinical results are announced. They rally in the fall as the conference schedule and the volume of news increases … Buy when the playing field is biased in my favor, and avoid it when it isn’t. “


Leave a Reply